HCG Side Effects: What’s Normal, What Isn’t and When to Stop

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

HCG Side Effects: What’s Normal, What Isn’t and When to Stop

Quick Answer: HCG (human chorionic gonadotropin) is well tolerated when used for legitimate clinical purposes — TRT fertility preservation, ovulation induction, and post-cycle therapy. Most users experience only mild injection-site reactions, occasional headaches, or transient water retention. The side effects that need active monitoring depend on context: in men, watch for elevated estradiol and mild gynaecomastia; in women undergoing ovulation induction, watch for ovarian hyperstimulation syndrome (OHSS); in PCT, watch for prolonged HPG-axis suppression if dosing is excessive. This guide breaks down what’s normal vs what isn’t by clinical context.

Side Effects by Clinical Context

HCG affects men, women, and protocol-specific users differently — the same molecule, but very different downstream consequences. This guide is organised by use case rather than by raw symptom list because clinical context determines which side effects are expected vs concerning.

HCG for Male TRT / Fertility Preservation (250–500 IU 2x/week)

Common, expected side effects:

• Mild injection-site reactions — redness, swelling, brief soreness at SubQ injection site; resolves within 24–48 h
• Mild fluid retention — 1–2 lb water weight gain in the first 2 weeks; usually self-limiting
• Slight increase in nipple sensitivity — common in the first 4 weeks as estradiol shifts; usually settles
• Occasional headache — typically resolves with hydration

Side effects that need management:

• Elevated estradiol — hCG stimulates testicular aromatase as a byproduct of Leydig cell activation, which can raise E2 levels. This compounds the aromatisation already occurring from TRT testosterone. Symptoms: nipple soreness becoming persistent, water retention beyond 2 weeks, mood lability, low libido despite high T. Manage with an aromatase inhibitor (anastrozole — see our anastrozole protocol guide) titrated to E2 level.
• Mild gynaecomastia — soft glandular tissue developing under the nipple. If progressing past 4 weeks, raise the AI dose or reduce hCG frequency.
• Polycythaemia (elevated haematocrit) — TRT itself raises haematocrit; hCG can amplify this slightly. Monitor every 12 weeks; therapeutic phlebotomy if Hct > 54%.

Red flags requiring assessment:

• Rapidly progressing breast tissue with pain or discharge
• Severe one-sided leg pain or swelling (rule out DVT — though hCG itself isn’t strongly associated, prolonged immobility + elevated estradiol can be)
• Sudden chest pain or shortness of breath (PE)
• Vision changes, severe headache, or facial weakness (rare neurovascular events)

HCG for Ovulation Induction (5,000–10,000 IU Single Dose)

Common, expected:

• Mild abdominal bloating starting 24–48 h post-injection
• Pelvic discomfort or mild cramping
• Breast tenderness
• Mood changes (mild)
• Injection-site reactions

Side effects that need management:

• Ovarian Hyperstimulation Syndrome (OHSS) — the major hCG-specific risk in women. hCG triggers multiple follicles to mature simultaneously after gonadotropin priming, and the resulting massive estradiol production drives capillary leakage and fluid shifts. Mild OHSS (4–8% of IVF cycles): abdominal distension, weight gain <2 kg, nausea. Moderate OHSS (1–2%): vomiting, weight gain 2–5 kg, ascites visible on ultrasound. Severe OHSS (<1%): rapid weight gain, oliguria, electrolyte derangement, thromboembolism risk — requires hospitalisation.
• Multiple pregnancy risk — hCG-triggered ovulation in stimulated cycles can produce twin or higher-order multiples; ultrasound monitoring before the trigger reduces but doesn’t eliminate this risk

Red flags after ovulation-induction hCG — seek emergency care for:

• Weight gain >1 kg/day or >2 kg over 3 days
• Severe abdominal pain, especially one-sided (rule out ovarian torsion)
• Reduced urine output
• Shortness of breath
• Leg pain or swelling (DVT — OHSS dramatically raises thrombotic risk)
• Severe vomiting/inability to keep fluids down

HCG for Post-Cycle Therapy (1,500–2,500 IU 2x/week for 2 weeks)

Common, expected:

• Increase in testicular size and sensitivity (this is the desired effect, but uncomfortable for some)
• Brief mood/libido changes as endogenous T begins to recover
• Mild gynaecomastia risk during the PCT window — see our complete PCT guide
• Acne flare-up as androgen output increases

Side effects requiring adjustment:

• Persistent HPG suppression from overuse — paradoxically, taking too much hCG for too long (e.g. 5,000+ IU daily for weeks) can keep LH suppressed by mimicking it so effectively that the pituitary doesn’t restart endogenous output. PCT hCG protocols should be time-limited (2 weeks max in most protocols) for this reason.
• Elevated estradiol during the bridge phase — hCG drives aromatase activity in the recovering testes; AI dosing may need adjustment
• Erratic libido — common during the transition phase as endogenous LH/FSH come back online

By Symptom: What’s Normal vs Concerning

Side Effects Specific to “Diet HCG” Protocols

The Simeons HCG diet (125–200 IU daily + 500 kcal/day) has been studied repeatedly and never shown to outperform placebo (see our HCG vs semaglutide for weight loss for the full breakdown). The side effects experienced in this protocol come almost entirely from the very-low-calorie diet, not the hCG itself:

Research spotlight: In Greenway and Bray’s 1977 placebo-controlled trial, the hCG and placebo groups had identical weight loss AND identical side-effect profiles when both followed the 500 kcal/day diet. The fatigue, dizziness, hair loss, irritability, mood depression, gallbladder symptoms, and electrolyte disturbances reported by hCG-diet participants are caused by the severe caloric restriction, not the injection.

VLCD-Specific Side Effects (Common to Both HCG-Diet and Placebo-Diet Arms)

• Gallstones — rapid weight loss + minimal fat intake; documented gallstone rates of 10–25% on VLCD protocols
• Electrolyte derangement — sodium, potassium, magnesium depletion; risk of cardiac arrhythmia
• Lean mass loss — without adequate protein, >30% of weight loss can come from muscle
• Hair shedding — telogen effluvium 2–4 months after the diet starts
• Cold intolerance, fatigue, low mood — adaptive thermogenesis effects
• Menstrual irregularities — energy deficit suppresses GnRH pulsatility

Drug Interactions

HCG has few clinically meaningful drug interactions. The main considerations:

• Aromatase inhibitors (anastrozole, exemestane) — commonly co-prescribed on TRT to manage estradiol; titrate to E2 level
• SERMs (clomiphene, tamoxifen) — used together in some PCT protocols; layered effect on HPG axis
• Anticoagulants — HCG may slightly elevate clotting factor levels in some users; if you’re on warfarin, monitor INR more frequently when starting hCG
• Lithium — case reports of lithium toxicity with sudden weight loss (relevant to diet HCG protocols)
• Insulin / sulfonylureas — energy intake changes during hCG protocols can affect glycaemic control

Contraindications and Precautions

Do not use HCG if:

• You have a known or suspected hormone-sensitive cancer (prostate cancer in men; breast/ovarian in women)
• You have undiagnosed abnormal uterine bleeding (women)
• You have active thrombophilia or recent VTE
• You’re pregnant (HCG is naturally elevated; supplementation isn’t indicated)
• You have a history of hypersensitivity to gonadotropin preparations
• You have an ovarian cyst not due to PCOS (women)

Use with caution if:

• Asthma, migraines, epilepsy, kidney disease, or cardiac disease (fluid retention concerns)
• Adolescents (consider growth-plate effects)
• Older men with prostate symptoms (HCG-driven testosterone increase may worsen BPH symptoms)

How to Manage Side Effects Without Stopping Treatment

For Mild Side Effects

• Hydration — most headaches and mild fluid retention resolve with 3+ L water/day
• Sodium moderation — reduce dietary sodium if fluid retention persists
• Rotate injection sites — abdomen, thigh, lateral arm; avoid same spot within 2 weeks
• Dose splitting — for TRT, split weekly dose into smaller more-frequent injections (e.g. EOD instead of 2x/week) to flatten peak-trough

For Estradiol-Related Symptoms (Men)

• Get baseline + 4-week E2 sensitive assay (LC/MS/MS preferred)
• Target E2 in the 20–40 pg/mL range
• Start anastrozole 0.25 mg twice weekly if E2 >40 with symptoms; titrate by E2 level
• See our anastrozole protocol for detail

When to Stop and Reassess

Permanent discontinuation is rare. Most issues resolve with dose adjustment, AI co-prescription, or injection scheduling. Stop and seek medical assessment for:

• Severe gynaecomastia not resolving with AI
• Persistent fluid retention with cardiovascular symptoms
• Any thromboembolic event
• OHSS (women)
• Allergic reactions
• Sustained elevation of liver enzymes

Frequently Asked Questions

Will HCG make me gain weight?

Short answer: a small amount of fluid weight (1–2 kg) in the first 2 weeks, which then plateaus or reverses. Long-term, hCG doesn’t cause fat gain. If you’re on hCG for TRT, the testosterone you’re also receiving may shift body composition (less fat, more muscle) — net scale weight may even rise from muscle gain.

Will HCG cause hair loss?

Not directly. HCG raises testosterone, which can accelerate male-pattern hair loss in genetically predisposed individuals. If you’re already on finasteride for hair, continue it; if not, monitor and add it if needed. See our Finpecia vs Propecia comparison.

Why do I feel emotional/irritable on HCG?

Estradiol shifts during the first 2–4 weeks of starting hCG can affect mood. Most users adapt by week 4–6. If symptoms persist, check E2 level and adjust AI dose. Severe mood changes warrant clinical assessment.

Can HCG cause cancer?

HCG itself does not cause cancer. However, it can stimulate growth of pre-existing hormone-sensitive cancers — which is why a history of prostate, breast, or ovarian cancer is a contraindication. Routine screening (PSA in men over 40) should continue per standard guidelines while on TRT/hCG.

Will I get gynaecomastia from HCG?

Possible but manageable. Mild nipple sensitivity is common in the first 4 weeks. True glandular tissue development is uncommon when E2 is controlled with appropriate AI dosing. Severe pre-existing gynaecomastia may worsen; surgical removal is the only definitive treatment for established glandular tissue.

How long can I stay on HCG?

For TRT fertility preservation: indefinitely, while on TRT. For PCT: 2 weeks typical. For ovulation induction: single doses. There’s no evidence that long-term low-dose hCG (250–500 IU 2x/week) causes Leydig cell desensitisation or any cumulative toxicity.

Can I drink alcohol while on HCG?

Moderate alcohol use doesn’t interact with hCG pharmacologically. Heavy alcohol use raises aromatase activity, increases E2, and worsens the same side effects (gynaecomastia, fluid retention) that hCG itself can cause. Moderation matters.

Medical Disclaimer: HCG protocols (TRT, fertility, PCT) require clinical context and baseline assessment. Always work with a qualified healthcare provider for dose selection, monitoring (testosterone, estradiol, haematocrit, PSA), and management of any concerning symptoms.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.